These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9209646)

  • 1. New knowledge about T-cell cytotoxicity.
    Cerottini JC; Tschopp J
    Ann Oncol; 1997; 8 Suppl 2():75-8. PubMed ID: 9209646
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis.
    Vergelli M; Hemmer B; Muraro PA; Tranquill L; Biddison WE; Sarin A; McFarland HF; Martin R
    J Immunol; 1997 Mar; 158(6):2756-61. PubMed ID: 9058810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxic mechanisms.
    Squier MK; Cohen JJ
    Curr Opin Immunol; 1994 Jun; 6(3):447-52. PubMed ID: 7522467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas and other cell death signaling pathways.
    Depraetere V; Golstein P
    Semin Immunol; 1997 Apr; 9(2):93-107. PubMed ID: 9194220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells.
    Screpanti V; Wallin RP; Grandien A; Ljunggren HG
    Mol Immunol; 2005 Feb; 42(4):495-9. PubMed ID: 15607805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line.
    Montel AH; Bochan MR; Goebel WS; Brahmi Z
    Cell Immunol; 1995 Oct; 165(2):312-7. PubMed ID: 7553897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
    Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
    J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
    Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
    Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection.
    Rode M; Balkow S; Sobek V; Brehm R; Martin P; Kersten A; Dumrese T; Stehle T; Müllbacher A; Wallich R; Simon MM
    J Virol; 2004 Nov; 78(22):12395-405. PubMed ID: 15507626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H; Hu HM; Urba WJ; Fox BA
    J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity.
    Doherty PC
    Cell; 1993 Nov; 75(4):607-12. PubMed ID: 7694805
    [No Abstract]   [Full Text] [Related]  

  • 15. Peritoneal exudate lymphocyte and mixed lymphocyte culture hybridomas are cytolytic in the absence of cytotoxic cell proteinases and perforin.
    Helgason CD; Prendergast JA; Berke G; Bleackley RC
    Eur J Immunol; 1992 Dec; 22(12):3187-90. PubMed ID: 1446710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteases and lymphocyte cytotoxic killing mechanisms.
    Hudig D; Ewoldt GR; Woodard SL
    Curr Opin Immunol; 1993 Feb; 5(1):90-6. PubMed ID: 8452680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perforin/granzymes pathway operates in xenogeneic human antipig cytotoxicity.
    Nakajima H; Fujiwara I; Matsuda T; Mizuta N; Oka T
    Transplant Proc; 1998 Feb; 30(1):76-8. PubMed ID: 9474962
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.
    Bachmann MF; Ohteki T; Faienza KM; Zakarian A; Kägi D; Speiser DE; Ohashi PS
    J Immunol; 1997 Nov; 159(9):4165-70. PubMed ID: 9379009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.